145 related articles for article (PubMed ID: 30312846)
1. An Efficient Bivalent Cyclic RGD-PIK3CB siRNA Conjugate for Specific Targeted Therapy against Glioblastoma In Vitro and In Vivo.
Cen B; Wei Y; Huang W; Teng M; He S; Li J; Wang W; He G; Bai X; Liu X; Yuan Y; Pan X; Ji A
Mol Ther Nucleic Acids; 2018 Dec; 13():220-232. PubMed ID: 30312846
[TBL] [Abstract][Full Text] [Related]
2. A bivalent cyclic RGD-siRNA conjugate enhances the antitumor effect of apatinib via co-inhibiting VEGFR2 in non-small cell lung cancer xenografts.
Liao L; Cen B; Li G; Wei Y; Wang Z; Huang W; He S; Yuan Y; Ji A
Drug Deliv; 2021 Dec; 28(1):1432-1442. PubMed ID: 34236267
[TBL] [Abstract][Full Text] [Related]
3. PIK3CB/p110β is a selective survival factor for glioblastoma.
Pridham KJ; Le L; Guo S; Varghese RT; Algino S; Liang Y; Fajardin R; Rodgers CM; Simonds GR; Kelly DF; Sheng Z
Neuro Oncol; 2018 Mar; 20(4):494-505. PubMed ID: 29016844
[TBL] [Abstract][Full Text] [Related]
4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
5. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma.
Esposito CL; Nuzzo S; Catuogno S; Romano S; de Nigris F; de Franciscis V
Mol Ther Nucleic Acids; 2018 Mar; 10():398-411. PubMed ID: 29499951
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of PIK3CB by siRNA suppresses malignant glioma cell growth in vitro and in vivo.
Pu P; Kang C; Zhang Z; Liu X; Jiang H
Technol Cancer Res Treat; 2006 Jun; 5(3):271-80. PubMed ID: 16700623
[TBL] [Abstract][Full Text] [Related]
7. Tumor-targeted in vivo gene silencing via systemic delivery of cRGD-conjugated siRNA.
Liu X; Wang W; Samarsky D; Liu L; Xu Q; Zhang W; Zhu G; Wu P; Zuo X; Deng H; Zhang J; Wu Z; Chen X; Zhao L; Qiu Z; Zhang Z; Zeng Q; Yang W; Zhang B; Ji A
Nucleic Acids Res; 2014 Oct; 42(18):11805-17. PubMed ID: 25223783
[TBL] [Abstract][Full Text] [Related]
8. Gelofusine Attenuates Tubulointerstitial Injury Induced by cRGD-Conjugated siRNA by Regulating the TLR3 Signaling Pathway.
Cen B; Liao W; Wang Z; Gao L; Wei Y; Huang W; He S; Wang W; Liu X; Pan X; Ji A
Mol Ther Nucleic Acids; 2018 Jun; 11():300-311. PubMed ID: 29858065
[TBL] [Abstract][Full Text] [Related]
9. RNAi-mediated gene knockdown and anti-angiogenic therapy of RCCs using a cyclic RGD-modified liposomal-siRNA system.
Sakurai Y; Hatakeyama H; Sato Y; Hyodo M; Akita H; Ohga N; Hida K; Harashima H
J Control Release; 2014 Jan; 173():110-8. PubMed ID: 24120854
[TBL] [Abstract][Full Text] [Related]
10. Survival kinase genes present prognostic significance in glioblastoma.
Varghese RT; Liang Y; Guan T; Franck CT; Kelly DF; Sheng Z
Oncotarget; 2016 Apr; 7(15):20140-51. PubMed ID: 26956052
[TBL] [Abstract][Full Text] [Related]
11. Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.
Cohen ZR; Ramishetti S; Peshes-Yaloz N; Goldsmith M; Wohl A; Zibly Z; Peer D
ACS Nano; 2015 Feb; 9(2):1581-91. PubMed ID: 25558928
[TBL] [Abstract][Full Text] [Related]
12. Preclinical therapeutic efficacy of a novel blood-brain barrier-penetrant dual PI3K/mTOR inhibitor with preferential response in PI3K/PTEN mutant glioma.
Koul D; Wang S; Wu S; Saito N; Zheng S; Gao F; Kaul I; Setoguchi M; Nakayama K; Koyama K; Shiose Y; Sulman EP; Hirota Y; Yung WKA
Oncotarget; 2017 Mar; 8(13):21741-21753. PubMed ID: 28423515
[TBL] [Abstract][Full Text] [Related]
13. Lycorine inhibits glioblastoma multiforme growth through EGFR suppression.
Shen J; Zhang T; Cheng Z; Zhu N; Wang H; Lin L; Wang Z; Yi H; Hu M
J Exp Clin Cancer Res; 2018 Jul; 37(1):157. PubMed ID: 30016965
[TBL] [Abstract][Full Text] [Related]
14. Epithelial membrane protein 1 promotes glioblastoma progression through the PI3K/AKT/mTOR signaling pathway.
Miao L; Jiang Z; Wang J; Yang N; Qi Q; Zhou W; Feng Z; Li W; Zhang Q; Huang B; Chen A; Zhang D; Zhao P; Li X
Oncol Rep; 2019 Aug; 42(2):605-614. PubMed ID: 31233190
[TBL] [Abstract][Full Text] [Related]
15. [Local shRNA modulation of phosphatidylinositol 3-kinase signaling pathway reduces intimal hyperplasia in vein grafts: experiment with rats].
Deng YZ; Liu SJ; Ma L; Sun ZQ; Chen JJ; Su G; Liu C; Wang GH; Ke J
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1713-6. PubMed ID: 17825157
[TBL] [Abstract][Full Text] [Related]
16. PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT.
Mecca C; Giambanco I; Bruscoli S; Bereshchenko O; Fioretti B; Riccardi C; Donato R; Arcuri C
Front Cell Neurosci; 2018; 12():99. PubMed ID: 29692710
[TBL] [Abstract][Full Text] [Related]
17. Connexin 43 confers chemoresistance through activating PI3K.
Pridham KJ; Shah F; Hutchings KR; Sheng KL; Guo S; Liu M; Kanabur P; Lamouille S; Lewis G; Morales M; Jourdan J; Grek CL; Ghatnekar GG; Varghese R; Kelly DF; Gourdie RG; Sheng Z
Oncogenesis; 2022 Jan; 11(1):2. PubMed ID: 35022385
[TBL] [Abstract][Full Text] [Related]
18. The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma.
Pridham KJ; Varghese RT; Sheng Z
Front Oncol; 2017; 7():312. PubMed ID: 29326882
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo evaluation of a novel 99mTc(CO)3-pyrazolyl conjugate of cyclo-(Arg-Gly-Asp-d-Tyr-Lys).
Alves S; Correia JD; Gano L; Rold TL; Prasanphanich A; Haubner R; Rupprich M; Alberto R; Decristoforo C; Santos I; Smith CJ
Bioconjug Chem; 2007; 18(2):530-7. PubMed ID: 17373771
[TBL] [Abstract][Full Text] [Related]
20. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
